{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:06Z","timestamp":1760028546983,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10554-019-01576-y","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T11:02:50Z","timestamp":1553511770000},"page":"1189-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-2373","authenticated-orcid":false,"given":"Ruben Y. G.","family":"Tijssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S. M.","family":"Kerkmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P.","family":"Kraak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kogame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ply","family":"Chichareon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Modolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah N.","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Sotomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd H.","family":"Hofma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene J.","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Karin","family":"Arkenbout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auke P. J. D.","family":"Weevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel A. M.","family":"Beijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G. P.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose P.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert J.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna J.","family":"Wykrzykowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"issue":"11","key":"1576_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4244\/EIJV9I11A217","volume":"9","author":"PW Serruys","year":"2014","unstructured":"Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Ormiston JA (2014) Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 9(11):1271\u20131284","journal-title":"EuroIntervention"},{"issue":"10","key":"1576_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","volume":"6","author":"Y Onuma","year":"2013","unstructured":"Onuma Y, Dudek D, Thuesen L, Webster M, Nieman K, Garcia-Garcia HM, Ormiston JA, Serruys PW (2013) Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv 6(10):999\u20131009","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"1576_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","volume":"10","author":"A Abizaid","year":"2015","unstructured":"Abizaid A, Ribamar Costa J Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW (2015) investigators AE. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention 10(12):1396\u20131401","journal-title":"EuroIntervention"},{"issue":"10059","key":"1576_CR4","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","volume":"388","author":"PW Serruys","year":"2016","unstructured":"Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iniguez A, Sabate M, Windecker S, Onuma Y (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388(10059):2479\u20132491","journal-title":"Lancet"},{"issue":"20","key":"1576_CR5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","volume":"373","author":"SG Ellis","year":"2015","unstructured":"Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW, Investigators AI (2015) Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 373(20):1905\u20131915","journal-title":"N Engl J Med"},{"issue":"24","key":"1576_CR6","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","volume":"376","author":"JJ Wykrzykowska","year":"2017","unstructured":"Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, AJ IJ, Elias J, van Dongen IM, Tijssen RYG, Koch KT, Baan J Jr, Vis MM, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS, Investigators A (2017) Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med 376(24):2319\u20132328","journal-title":"N Engl J Med"},{"issue":"23","key":"1576_CR7","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","volume":"70","author":"DJ Kereiakes","year":"2017","unstructured":"Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW, Investigators AI (2017) 3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial. J Am Coll Cardiol 70(23):2852\u20132862","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"1576_CR8","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.4244\/EIJY17M02_01","volume":"12","author":"PW Serruys","year":"2017","unstructured":"Serruys PW, Onuma Y (2017) Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist\u2019s jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS? EuroIntervention 12(17):2047\u201356","journal-title":"EuroIntervention"},{"issue":"12","key":"1576_CR9","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","volume":"7","author":"Y Onuma","year":"2014","unstructured":"Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia HM, Veldhof S, Rapoza R, Ormiston JA (2014) Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv 7(12):1400\u20131411","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"1576_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jcin.2016.03.027","volume":"9","author":"P Suwannasom","year":"2016","unstructured":"Suwannasom P, Sotomi Y, Ishibashi Y, Cavalcante R, Albuquerque FN, Macaya C, Ormiston JA, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Tijssen JG, Wykrzykowska JJ, de Winter RJ, Chevalier B, Serruys PW, Onuma Y (2016) The impact of post-procedural asymmetry, expansion, and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial. JACC Cardiovasc Interv 9(12):1231\u20131242","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"1576_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ccd.23177","volume":"79","author":"V Farooq","year":"2012","unstructured":"Farooq V, Gomez-Lara J, Brugaletta S, Gogas BD, Garcia-Garcia HM, Onuma Y, van Geuns RJ, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW (2012) Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study. Catheter Cardiovasc Interv 79(6):880\u2013888","journal-title":"Catheter Cardiovasc Interv"},{"issue":"13","key":"1576_CR12","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jcin.2015.07.026","volume":"8","author":"Y Ishibashi","year":"2015","unstructured":"Ishibashi Y, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Garcia-Garcia HM, Bartorelli AL, Whitbourn R, Chevalier B, Abizaid A, Ormiston JA, Rapoza RJ, Veldhof S, Onuma Y, Serruys PW (2015) Relation Between bioresorbable scaffold sizing using QCA-Dmax and clinical outcomes at 1 Year in 1,232 patients from 3 study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II). JACC Cardiovasc Interv 8(13):1715\u20131726","journal-title":"JACC Cardiovasc Interv"},{"key":"1576_CR13","doi-asserted-by":"publisher","first-page":"e1057","DOI":"10.4244\/EIJ-D-18-00301","volume":"14","author":"Y Katagiri","year":"2018","unstructured":"Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek JJ, Wykrzykowska JJ, Abizaid A, Ormiston JA, Chevalier B, Serruys PW (2018) Relation between Bioresorbable Scaffold Sizing Using QCA-Dmax and Long-term Clinical Outcomes in 1,232 Patients from 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II). EuroIntervention 14:e1057\u20131066","journal-title":"EuroIntervention"},{"issue":"5","key":"1576_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ahj.2012.08.010","volume":"164","author":"R Diletti","year":"2012","unstructured":"Diletti R, Serruys PW, Farooq V, Sudhir K, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Onuma Y, Garcia-Garcia HM, Chevalier B (2012) ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Am Heart J 164(5):654\u2013663","journal-title":"Am Heart J"},{"doi-asserted-by":"crossref","unstructured":"Tijssen RYG, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout K, Weevers A, Elias J, van Dongen IM, Koch KT, Baan J Jr, Vis M, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS, Wykrzykowska JJ. Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI. EuroIntervention. 2018","key":"1576_CR15","DOI":"10.4244\/EIJ-D-18-00335"},{"issue":"2","key":"1576_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ahj.2013.09.017","volume":"167","author":"P Woudstra","year":"2014","unstructured":"Woudstra P, Grundeken MJ, Kraak RP, Hassell ME, Arkenbout EK, Baan J Jr, Vis MM, Koch KT, Tijssen JG, Piek JJ, de Winter RJ, Henriques JP, Wykrzykowska JJ (2014) Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design. Am Heart J 167(2):133\u2013140","journal-title":"Am Heart J"},{"issue":"4","key":"1576_CR17","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.4244\/EIJ-D-17-01152","volume":"14","author":"RYG Tijssen","year":"2018","unstructured":"Tijssen RYG, Kraak RP, Elias J, van Dongen IM, Kalkman DN, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek JJ, Henriques JPS, de Winter RJ, Tijssen JGP, Onuma Y, Serruys PW, Wykrzykowska JJ (2018) Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial. EuroIntervention 14(4):e434\u2013e442","journal-title":"EuroIntervention"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-019-01576-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:12:08Z","timestamp":1585008728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-019-01576-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1007\/s10554-019-01576-y","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"type":"print","value":"1569-5794"},{"type":"electronic","value":"1573-0743"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Amsterdam UMC Heart Center received an unrestricted educational research grant from Abbott Vascular for the AIDA trial. The Research Department of the cardiology division of the Medical Center Leeuwarden received non-study related unrestricted educational research grants from Abbott Vascular. J.J. Wykrzykowska receives consultancy fees and research grants from Abbott Vascular. J.P.S Henriques receives research grants from Abbott Vascular. J.J. Piek is a member of the Medical Advisory Board of Abbott Vascular. J.G.P. Tijssen served on the DSMB of the early ABSORB trials, including ABSORB II. The other co-authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}